Brevan Howard Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,056
Closed -$39.4K 1065
2024
Q1
$39.4K Buy
+18,056
New +$39.4K ﹤0.01% 899